These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 19702912

  • 1. Effect of dietary fat to produce non-alcoholic fatty liver in the rat.
    Ahmed U, Redgrave TG, Oates PS.
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1463-71. PubMed ID: 19702912
    [Abstract] [Full Text] [Related]

  • 2. Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.
    Liu X, Henkel AS, LeCuyer BE, Schipma MJ, Anderson KA, Green RM.
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec 15; 309(12):G965-74. PubMed ID: 26472223
    [Abstract] [Full Text] [Related]

  • 3. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).
    Tipoe GL, Ho CT, Liong EC, Leung TM, Lau TY, Fung ML, Nanji AA.
    Histol Histopathol; 2009 Sep 15; 24(9):1161-9. PubMed ID: 19609863
    [Abstract] [Full Text] [Related]

  • 4. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
    Cai YQ, Zhang LZ, Wang DJ, Chen FM, Chen ZY, Zhu KY, Li JS, Yan MX.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep 15; 30(5):465-70. PubMed ID: 25571645
    [Abstract] [Full Text] [Related]

  • 5. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ, Leeming DJ, Detlefsen S, Bruun MF, Hjuler ST, Henriksen K, Hein P, Karsdal MA, Brockbank S, Cruwys S.
    Biomed Pharmacother; 2019 Mar 15; 111():926-933. PubMed ID: 30841472
    [Abstract] [Full Text] [Related]

  • 6. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
    Qin R, Zhang J, Li C, Zhang X, Xiong A, Huang F, Yin Z, Li K, Qin W, Chen M, Zhang S, Liang L, Zhang H, Nie H, Ye W.
    Arch Pharm Res; 2012 Jul 15; 35(7):1241-50. PubMed ID: 22864747
    [Abstract] [Full Text] [Related]

  • 7. Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
    Xu P, Zhang XG, Li YM, Yu CH, Xu L, Xu GY.
    J Zhejiang Univ Sci B; 2006 Aug 15; 7(8):627-33. PubMed ID: 16845716
    [Abstract] [Full Text] [Related]

  • 8. Model of nonalcoholic steatohepatitis.
    Lieber CS, Leo MA, Mak KM, Xu Y, Cao Q, Ren C, Ponomarenko A, DeCarli LM.
    Am J Clin Nutr; 2004 Mar 15; 79(3):502-9. PubMed ID: 14985228
    [Abstract] [Full Text] [Related]

  • 9. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
    Baumgardner JN, Shankar K, Hennings L, Badger TM, Ronis MJ.
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan 15; 294(1):G27-38. PubMed ID: 17947452
    [Abstract] [Full Text] [Related]

  • 10. The effect of rat strain, diet composition and feeding period on the development of a nutritional model of non-alcoholic fatty liver disease in rats.
    Kučera O, Garnol T, Lotková H, Staňková P, Mazurová Y, Hroch M, Bolehovská R, Roušar T, Červinková Z.
    Physiol Res; 2011 Jan 15; 60(2):317-28. PubMed ID: 21114362
    [Abstract] [Full Text] [Related]

  • 11. High fructose feeding induces copper deficiency in Sprague-Dawley rats: a novel mechanism for obesity related fatty liver.
    Song M, Schuschke DA, Zhou Z, Chen T, Pierce WM, Wang R, Johnson WT, McClain CJ.
    J Hepatol; 2012 Feb 15; 56(2):433-40. PubMed ID: 21781943
    [Abstract] [Full Text] [Related]

  • 12. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
    Yalniz M, Bahcecioglu IH, Kuzu N, Poyrazoglu OK, Bulmus O, Celebi S, Ustundag B, Ozercan IH, Sahin K.
    J Gastroenterol Hepatol; 2007 Nov 15; 22(11):2009-14. PubMed ID: 17914984
    [Abstract] [Full Text] [Related]

  • 13. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
    Zhang DM, Zhang GY, Wang T, Zhong HJ, Chen WK.
    Zhonghua Yi Xue Za Zhi; 2006 May 16; 86(18):1279-83. PubMed ID: 16796890
    [Abstract] [Full Text] [Related]

  • 14. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
    Hong XZ, Li LD, Wu LM.
    Clin Exp Pharmacol Physiol; 2007 May 16; 34(1-2):27-35. PubMed ID: 17201732
    [Abstract] [Full Text] [Related]

  • 15. Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats.
    de Castro UG, dos Santos RA, Silva ME, de Lima WG, Campagnole-Santos MJ, Alzamora AC.
    Lipids Health Dis; 2013 Sep 18; 12():136. PubMed ID: 24044579
    [Abstract] [Full Text] [Related]

  • 16. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis.
    Daniels SJ, Leeming DJ, Detlefsen S, Bruun MF, Hjuler ST, Henriksen K, Hein P, Krag A, Karsdal MA, Nielsen MJ, Brockbank S, Cruwys S.
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar 01; 318(3):G410-G418. PubMed ID: 31905026
    [Abstract] [Full Text] [Related]

  • 17. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis.
    Asano T, Watanabe K, Kubota N, Gunji T, Omata M, Kadowaki T, Ohnishi S.
    J Gastroenterol Hepatol; 2009 Oct 01; 24(10):1669-76. PubMed ID: 19788607
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
    Tang Y, Bian Z, Zhao L, Liu Y, Liang S, Wang Q, Han X, Peng Y, Chen X, Shen L, Qiu D, Li Z, Ma X.
    Clin Exp Immunol; 2011 Nov 01; 166(2):281-90. PubMed ID: 21985374
    [Abstract] [Full Text] [Related]

  • 19. Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.
    Gao Y, Song LX, Jiang MN, Ge GY, Jia YJ.
    Inflammation; 2008 Apr 01; 31(2):121-32. PubMed ID: 18302012
    [Abstract] [Full Text] [Related]

  • 20. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ, Yeh MM, Van Rooyen DM, Teoh NC, Brooling J, Hou JY, Williams J, Clyne M, Nolan CJ, Farrell GC.
    J Gastroenterol Hepatol; 2009 Oct 01; 24(10):1658-68. PubMed ID: 19788606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.